Hims & Hers Health (HIMS) Competitors $59.12 -3.64 (-5.80%) Closing price 10/16/2025 03:59 PM EasternExtended Trading$56.49 -2.63 (-4.45%) As of 10/16/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, FMS, GH, RDNT, BTSG, SHC, OPCH, WGS, PRVA, and HTFLShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care AG & Co. KGaA (FMS), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Privia Health Group (PRVA), and Heartflow (HTFL). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Its Competitors Natera Fresenius Medical Care AG & Co. KGaA Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx Privia Health Group Heartflow Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership. Do analysts recommend HIMS or NTRA? Hims & Hers Health presently has a consensus price target of $38.92, suggesting a potential downside of 34.17%. Natera has a consensus price target of $194.06, suggesting a potential upside of 7.49%. Given Natera's stronger consensus rating and higher possible upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 3 Sell rating(s) 9 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.93Natera 1 Sell rating(s) 1 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 2.90 Which has more risk & volatility, HIMS or NTRA? Hims & Hers Health has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.74, suggesting that its stock price is 74% more volatile than the S&P 500. Which has better valuation and earnings, HIMS or NTRA? Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B9.05$126.04M$0.8073.90Natera$1.70B14.60-$190.43M-$1.91-94.52 Is HIMS or NTRA more profitable? Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health9.63% 26.26% 13.06% Natera -12.89%-22.22%-15.03% Do institutionals and insiders hold more shares of HIMS or NTRA? 63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 13.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 5.6% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media refer more to HIMS or NTRA? In the previous week, Hims & Hers Health had 12 more articles in the media than Natera. MarketBeat recorded 34 mentions for Hims & Hers Health and 22 mentions for Natera. Hims & Hers Health's average media sentiment score of 0.75 beat Natera's score of 0.65 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 15 Very Positive mention(s) 6 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 7 Very Positive mention(s) 5 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive SummaryHims & Hers Health beats Natera on 10 of the 17 factors compared between the two stocks. Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$14.18B$2.35B$6.09B$21.97BDividend YieldN/AN/A5.73%3.59%P/E Ratio73.9041.1385.0732.64Price / Sales9.0513.04604.9982.90Price / Cash178.2165.0637.8624.53Price / Book27.3712.7212.394.62Net Income$126.04M-$65.79M$3.32B$1.01B7 Day Performance9.52%4.44%2.30%1.64%1 Month Performance17.49%12.82%9.67%-0.07%1 Year Performance174.21%36.15%73.80%11.46% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health2.8515 of 5 stars$59.12-5.8%$38.92-34.2%+164.4%$14.18B$1.48B73.901,637Trending NewsAnalyst ForecastInsider TradeOptions VolumeNTRANatera2.1286 of 5 stars$173.15+2.3%$192.88+11.4%+42.4%$23.76B$1.70B-90.654,434Analyst ForecastShort Interest ↑FMSFresenius Medical Care AG & Co. KGaA4.3146 of 5 stars$27.42+2.2%$27.80+1.4%+34.8%$16.09B$19.52B22.471,384News CoverageAnalyst DowngradeShort Interest ↓GHGuardant Health3.8193 of 5 stars$62.31-3.0%$65.86+5.7%+212.1%$7.77B$828.85M-18.602,021RDNTRadNet3.263 of 5 stars$71.66+1.5%$76.80+7.2%+10.0%$5.51B$1.83B-358.0111,021Positive NewsAnalyst UpgradeBTSGBrightSpring Health Services2.8383 of 5 stars$29.45+3.8%$30.50+3.6%+85.7%$5.22B$11.27B95.0035,000News CoverageAnalyst ForecastSHCSotera Health2.859 of 5 stars$15.73+2.5%$17.20+9.4%+2.6%$4.47B$1.10B196.593,000OPCHOption Care Health4.8325 of 5 stars$26.56-0.6%$35.11+32.2%-12.3%$4.31B$5.37B21.258,088Positive NewsWGSGeneDx2.6006 of 5 stars$118.74-2.5%$104.13-12.3%+94.8%$3.41B$305.45M2,375.101,200News CoveragePRVAPrivia Health Group3.1142 of 5 stars$24.12+0.1%$28.91+19.9%+41.0%$2.96B$1.74B219.381,140HTFLHeartflowN/A$34.05+1.7%$36.60+7.5%N/A$2.84BN/A0.00699Positive News Related Companies and Tools Related Companies NTRA Competitors FMS Competitors GH Competitors RDNT Competitors BTSG Competitors SHC Competitors OPCH Competitors WGS Competitors PRVA Competitors HTFL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
